Shenzhen Jianyuan Biotechnology

Shenzhen Jianyuan Biotechnology is an innovative biopharmaceutical company based in Shenzhen, China, specializing in the development of next-generation peptide therapeutics. The company utilizes a proprietary synthetic biology platform to design and optimize multi-target peptide agonists for metabolic and endocrine disorders. Their primary research focus includes long-acting treatments for obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH). By integrating advanced computational design with high-throughput screening, Jianyuan Bio aims to accelerate the transition of novel peptide candidates from discovery to clinical application. The firm is currently advancing several lead programs, including dual and triple receptor agonists, through the pre-clinical pipeline.